Search clinical trials for: Standard Risk ALL

Total 471680 results

Austin Health

Completed

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge (PALACE)

Hypersensitivity, Immediate | Hypersensitivity, Delayed | Hypersensitivity Response

United States, Australia, Canada
William Beaumont Hospitals

Withdrawn

Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct (CRASCH-Liver)

Coronary Artery Disease | Acute Liver Failure | Liver Transplant

United States
CardioRenal Systems, Inc.

Active, not recruiting

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients (CIN-RG)

Contrast Induced Nephropathy

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia in Remission | Refractory Anemia With Excess Blasts | Refractory... and other conditions

United States
University College London Hospitals
University College, London

Completed

Communicating Risks: Consent for Lumbar Puncture

Informed Consent, Health Literacy, Risk, Spinal Puncture, Neurosurgery

United Kingdom
Celgene

Active, not recruiting

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)

Multiple Myeloma

United States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
University of California, San Francisco
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Withdrawn

Cigarette Harm Reduction With Electronic Cigarette Use (NIDA-SREC)

Cardiovascular Risk Factor | Nicotine Dependence | Nicotine Dependence, Cigarettes | Nicotine Withdrawal | Tobacco Toxicity

United States
Ruijin Hospital

Active, not recruiting

Reduced Chemotherapy in Low Risk DLBCL

Diffuse Large B-cell Lymphoma

China
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Melanoma | Health Status Unknown | Dysplastic Nevus | No Evidence of Disease

United States
University Hospital, Bonn

Completed

Transcatheter Aortic Valve Implantation Without Predilation (SIMPLIFy TAVI)

Aortic Stenosis | Left Ventricular Function Systolic Dysfunction | High-risk Patients | Transcatheter Aortic Valve Implantation

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Negative

United States
University of Turin, Italy

Completed

Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency Department

Syncope

Italy
Sahlgrenska University Hospital, Sweden
NU-Hospital Organization, Sweden

Active, not recruiting

Standardized Perioperative Management of Patients Operated With Acute Abdominal Surgery in a High-risk Emergency Setting (SMASH)

Peritonitis | Ileus | Laparotomy | Acute Abdomen | Perforated Bowel

Sweden
St. Luke's Medical Center, Philippines
Icahn School of Medicine at Mount Sinai; University of Copenhagen; Nanyang Technological...

Completed

Filipino Multicomponent Intervention to Maintain Cognitive Performance in High Risk Population (FINOMAIN) (FINOMAIN)

Mild Cognitive Impairment

Philippines
John Levine
Biogen

Completed

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Acute Graft Versus Host Disease

United States
Hospital of South West Jutland
Novo Nordisk A/S; Ribe County Hospital

Completed

Different Insulin Regimens and Postprandial Coagulation Activation

Inflammation | Type 2 Diabetes | Cardiovascular Risk | Hemostasis | Endothelial Function

Denmark
Albert Einstein College of Medicine
National Institute of Mental Health (NIMH); HIV Center for Clinical & Behavioral...

Completed

PC4PrEP: Integrating PrEP Into Primary Care (PC4PrEP)

Human Immunodeficiency Virus Transmission

United States
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
University of California, Davis
Lao Tropical and Public Health Institute

Completed

Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders

Thiamine Deficiency

Lao People's Democratic Republic
Lawson Health Research Institute
The Ottawa Hospital

Completed

A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer

Breast Neoplasms

Canada
3M

Completed

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Surgical Wound Infection | Surgical Site Infection | Post-operative Complications

United States
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
Brugmann University Hospital

Completed

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

Hemorrhage | Peripartum Period | HEMSTOP Questionnaire

Belgium
University of Pennsylvania

Completed

Can Birthly, an Online Childbirth Education Platform, Reduce Pregnancy-related Anxiety Compared to Usual Care (Birthly)

Pregnancy, High Risk

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Donor | Hematopoietic Cell Transplant Recipient | HLA-A*0201 Positive Cells Present

United States
Erasme University Hospital

Completed

Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery

Cardiac Surgery | General Anesthesia | Hemodynamic Instability | Nociceptive Pain | Goal-directed Therapy | Nol-Index | Remifentanil | Vascular Surgery

Belgium
University Hospital, Lille
Ministry of Health, France

Completed

Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease (COVARAD)

Alzheimer's Disease | Cardiovascular Risk Factors

France
The University of Hong Kong

Completed

ESM-derived Personalised Feedback for Women at Risk of Common Mental Disorder

Women at Risk of Common Mental Disorders

Hong Kong
RCSI & UCD Malaysia Campus

Completed

Time Restricted Feeding to Reduce Weight and Cardiometabolic Risk

Obesity | Metabolic Syndrome | Pre Diabetes

Malaysia
Institute of Liver and Biliary Sciences, India

Completed

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.

Spontaneous Bacterial Peritonitis

India
University of California, San Francisco

Withdrawn

Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk (STIFLE-RISK)

Infection | Transplant;Failure,Kidney

United States
Icahn School of Medicine at Mount Sinai
International Biophysics Corporation; SPARK Healthcare

Terminated

Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic

Covid19 | Chronic Obstructive Pulmonary Disease | Chronic Cough

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
Umeå University

Active, not recruiting

Sleeve Gastrectomy as a Standard Bariatric Procedure

Postoperative Complications

Sweden
NSABP Foundation Inc
Genentech, Inc.; US Oncology Research

Completed

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Breast Cancer

United States, Ireland
Nanfang Hospital of Southern Medical University
Xiangya Hospital of Central South University; Guangzhou First People's Hospital and other collaborators

Completed

BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Acute Lymphocytic Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Busulfan | Total Body Irradiation

China
Vanderbilt University Medical Center

Withdrawn

Family at Risk Study (FAR)

Stroke | Hypertension

United States
University Hospital, Bordeaux

Completed

Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care (ARIBO)

Cystitis

France
Brown University
The Miriam Hospital; Rhode Island Hospital

Completed

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Prostate Cancer

United States
University Hospital, Bordeaux

Completed

AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding (APACHE)

Cardiac Surgery | Cardiopulmonary Bypass | High Risk Bleeding

France
Organon and Co

Withdrawn

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) (VYCTORY)

Dyslipidemia
Heinrich-Heine University, Duesseldorf
The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit...

Completed

Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals (RES-Q-HR)

Corona Virus Infection | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 PCR Test Positive

Germany
University of Adelaide

Completed

Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)

Individuals at Risk of Developing Diabetes

Australia
Nutricia Research

Withdrawn

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy (MAESTRO)

Immunity
Baylor Research Institute

Active, not recruiting

Giving a Low Carbohydrate Diet to Overcome Hypertension (GLOH)

Hypertension | Risk Reduction Behavior | African Americans | Diet, Carbohydrate-Restricted

United States
Nutricia Research

Completed

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy (TEMPO)

Immunity

Hong Kong, Taiwan, Singapore, Netherlands, Israel, Spain, United Kingdom, Slovakia, Belgium, Germany, Czechia, Hungary, Italy
Luzerner Kantonsspital

Completed

Lucerne Fall Risk Prediction Score for Stroke Rehabilitation (L-PRESTO)

Stroke

Switzerland
National Institute of Allergy and Infectious Diseases...
Schering-Plough

Completed

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

HIV Infections | Lymphoma, Non-Hodgkin

United States
National Institute of Allergy and Infectious Diseases...

Completed

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

HIV Infections | Lymphoma, Non-Hodgkin

United States
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Acute GVHD

United States

Search clinical trials for: Standard Risk ALL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations